...
首页> 外文期刊>Korean Circulation Journal >Early Assessment of Reperfusion Therapy in Acute Myocardial Infarction Using Cardiac Troponin-T
【24h】

Early Assessment of Reperfusion Therapy in Acute Myocardial Infarction Using Cardiac Troponin-T

机译:心肌肌钙蛋白-T在急性心肌梗死中的再灌注治疗的早期评估

获取原文
           

摘要

Background An earlier index of reperfusion is desirable to determine whether additional therapy is necessary for myocardial salvage. Using the washout phenomenon of biochemical markers, many investigator have reported noninvasive methods for detection coronary reperfusion in patients with acute myocardial infarction. Recently cardiac Troponin-T has been developed as a new myocardial specific marker, especially myocardial damage. The object of this study is to investigate the utility of cardiac Troponin-T for early assessment of reperfusion therapy. Methods The study group comprised 10 patients with acute myocardial infarction and reperfusion therapy that was initiated within 6 hours after the onset of symptoms. Blood samples were taken before treatment, every 30 min interval for 3 hours and then 6, 24, 72 hours after the onset of reperfusion therapy to measuring Troponin-T, Creatin Kinase(CK), and CK-MB level. Serum concentration of cardiac Troponin-T level was measured with immunoassed using ES-300, Boehringer Mannheim. We compared the real reperfusion that was assessed by coronary angiogram, chest pain disappearence and resolusion of St-segment elevation with an index of coronary reperfusion, the increase in Troponin-T(△ Troponin-T) 60, 90 min after repefusion therapy(Successful Reperfusion Index : Tn-T 60(90)-0>0.3 ng/ml) and the sensitivity, specificity, Positive, and negative predictive value were calculated using this threshold(Successful Reperfusion Index). Results 1) The studied patients(M/F : 7/3, mean age 54±12 year) were treated within 3 hour with thrombolytic therapy(7 patients, t-PA) or emergency angioplasty(3 patients). 2) The cardiac Troponin-T levels in eight patients with successful reperfusion showed early peak within 24 hours after reperfusion therapy were initiated but in 2 patients without successful reperfusion showed sustained increase without early peak within 24 hours. The CK-MB levels in patients with successful reperfusion also showed early peak within 24 hours but 5 of 8 patients showed no significant increase until 2 hours after reperfusion therapy. 3) The sensivity, specificity, positive and negative predictive value for detecting reperfusion using a threshold value of 0.3 ng/ml of △ Troponin-T 90 min(60 min) after reperfusion therapy was 100%(56%), 50(100%), 89%(100%), and 100%(20%), respectively. Conclusion Serial measurements of cardiac Troponin-T, especially reperfusion index(0.3 ng/ml of △ Troponin-T 90 min after reperfusion therapy) are useful for early assessment of reperfusion therapy in acute myocardial infarction.
机译:背景技术较早的再灌注指数是确定心肌挽救是否需要额外治疗所需要的。利用生化标记物的洗脱现象,许多研究人员报告了用于检测急性心肌梗死患者冠状动脉再灌注的非侵入性方法。最近,心脏肌钙蛋白-T已被开发为一种新的心肌特异性标志物,尤其是心肌损伤。这项研究的目的是研究心肌肌钙蛋白-T在早期评估再灌注治疗中的实用性。方法研究组包括10例急性心肌梗塞和再灌注治疗患者,这些患者在症状发作后6小时内开始治疗。在治疗前,每30分钟间隔3小时,然后在再灌注治疗开始后的6、24、72小时采集血样,以测量肌钙蛋白T,肌酐激酶(CK)和CK-MB水平。使用Boehringer Mannheim的ES-300免疫评估血清心肌肌钙蛋白T水平的浓度。我们将通过冠状动脉血管造影评估的真实再灌注,胸痛消失和St段抬高的消失与冠状动脉再灌注指数,再灌注治疗后90、60分钟肌钙蛋白-T(△肌钙蛋白-T)的升高进行了比较(成功再灌注指数:Tn-T 60(90)-0> 0.3 ng / ml),并使用此阈值(成功再灌注指数)计算敏感性,特异性,阳性和阴性预测值。结果1)研究对象(男/女:7/3,平均年龄54±12岁)在3小时内接受了溶栓治疗(7例,t-PA)或急诊血管成形术(3例)。 2)8例成功再灌注的患者的心肌肌钙蛋白T水平在开始再灌注治疗后24小时内显示早期峰值,但2例未成功再灌注的患者显示24小时内持续升高而没有早期峰值。成功再灌注患者的CK-MB水平也显示在24小时内达到早期高峰,但是8名患者中有5个直到再灌注治疗后2小时才显示出明显升高。 3)再灌注治疗后90 min(60 min)以0.3 ng / ml△肌钙蛋白-T的阈值检测再灌注的敏感性,特异性,正负预测值分别为100%(56%),50(100%) ),89%(100%)和100%(20%)。结论连续测定心肌肌钙蛋白-T,特别是再灌注指数(再灌注治疗后90 min△肌钙蛋白-T 0.3 ng / ml),有助于早期评估急性心肌梗死的再灌注治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号